Life Sciences

Frost & Sullivan's expertise in Life Sciences research and consulting includes work in diversified strategic and operational areas

The life sciences industry is undergoing rapid change, dynamic discoveries and pressures driving business decisions and corporate growth. Business models are being forced to evolve as healthcare continues to shift from a treatment focus to points of wellness, prediction, personalization, and prevention.

Recognizing the interdependence of the payer, provider and pharmaceutical value chains, companies are re-inventing strategies in multitude ways: increased outsourcing, co-development and patient engagement are the new norms.

The Frost & Sullivan Global Life Sciences Program helps you better understand stakeholder dynamics as the healthcare system transitions from acute care into integrated care. Our research and insights help you make informed strategic decisions around how best to navigate this complex market.

We can support needs from syndicated research to projects ranging from proprietary strategic engagements and market research, marketing solutions, and whitepapers, all leveraging the global reach of our firm to propel your business forward.

We believe a structured partnership that provides you transformational insights through online content as well as deeper interaction with our senior analyst team will help ensure greater relevancy of insights provided for your organization.

  1. 30 Dec 2013  |  Europe

    The Untapped Potential in Live Cell Imaging (Technical Insights)

    Improved cellular dynamics in disease diagnostic and drug discovery.

    The study covers provides an assessment of the marketed and pipeline products for the global human albumin market. Segmentation by application has been provided along with additional information such as clinical trial timelines and results, and historical and projected launch timelines. The marketed and pipeline products have been broadly segmented...

    $4,950.00
  2. 27 Dec 2013  |  Global

    Emerging Technologies in Infectious Diseases Diagnostics (Technical Insights)

    Infectious diseases diagnostics for the developing world

    This research service focuses on the emerging diagnostic technologies (for TB, HIV, HCV, HPV), the developmental initiatives, corporate developments by market leaders, and the role of international organizations within this market. It enlists end-user demands. The research service discusses the existing healthcare structure within the developing re...

    $4,950.00
  3. 26 Dec 2013  |  Global

    Technology Breakthroughs in Aesthetic Procedures (Technical Insights)

    Advancements in laser technology to significantly increase non-invasive aesthetic procedures.

    Aesthetic procedures though cost intensive in nature, has experienced increased growth over the past decade. Companies have and are coming up in this space with all-inclusive vacation cum procedure packages which are alluring patients to undergo such procedures.  Since such procedures are not covered by health insurance, price is the major selling...

    $4,950.00
  4. 19 Dec 2013  |  Global

    Trends, Opportunities, and Challenges for the Latin American Diabetes Therapeutics Market

    Innovative Drugs to Launch in the Next 3 Years, Impacting the Insulin and Non-insulin Markets

    Biomarkers are no longer mere tools used to measure the criteria of a biological process characteristic. They are being increasingly used in patient stratification and customised medical interventions. This research service presents an overview and analysis of the global biomarker market. It provides revenue forecasts for biomarker on technological...

    $2,450.00
  5. 12 Dec 2013  |  Latin America

    Analysis of the Brazilian Market for Reagent Kits in In Vitro Diagnosis

    Healthcare Investments in the Public Sector Will Increase Market Growth

    Despite Brazilian economic and industry challenges, the market for reagent kits in in vitro diagnosis (IVD) is experiencing robust growth. This research service leverages primary research that includes several companies manufacturing and marketing reagent kits in IVD, companies distributing or buying these products, and IVD experts, as well as seco...

    $6,950.00
  6. 11 Dec 2013  |  Global

    Analysis of the US Retinal Therapeutics Market

    Improvements in Administration and Efficacy Drive Growth

    The global diabetes drug delivery market is mainly divided into injectable drug delivery and oral drug delivery systems. The trend will continue in 2015, as four major products: Afrezza (inhalable drug delivery product of MannKind distributed by Sanofi), Tanzeum (injectable pen), Xigduo XR (oral), and Xultophy (injectable pen) enter the US and Euro...

    $4,950.00
  7. 03 Dec 2013  |  North America

    Analysis of the Global Tissue Diagnostics Market

    Reimbursement Cuts and Hospital Consolidation Impede Uptake of Automated Equipment in Laboratories

    This study investigates the global tissue diagnostics market for the period 2009 to 2017. The geographic regions are the US, Western Europe, APAC, and ROW through which the market is broadly classified by the advance stains segment and the pre-analytical segment. The study also includes a competitive analysis (SWOT), product analysis, revenue forec...

    $10,000.00
  8. The study assesses marketed and investigational products and combination regimens for the global breast cancer therapeutics market. Segmentation by drug class is provided, along with supporting information, such as clinical trial timelines and results, historical and projected launch timelines, and epidemiology. Marketed and pipeline products are b...

    $4,950.00
  9. 31 Oct 2013  |  Global

    Chinas 2013 Life Sciences Industry Outlook and Regulatory Review

    Government Investments Could Make China the Third-largest Pharmaceutical Market in the World

    China is predicted to become the third-largest pharmaceutical market in the world by the end of 2013 due to the governments considerable investment in the healthcare industry and the populations unmet healthcare needs. The life sciences industry is broad and involves a wide range of disciplines. This research service focuses on the trends and mar...

    $4,950.00
  10. 28 Oct 2013  |  Global

    Competing in the Global Contract Manufacturing Market

    What Pharmaceutical and Biotechnology Companies Want and How to Compete for their Business

    The overall objective of this study was to provide contract manufacturing organizations (CMOs) a sound basis for formulating an effective strategy to compete in the market, including areas of opportunities and threats. As far as the market dynamics and CMO selection are concerned, overall satisfaction and likelihood of contract renewal are in the 4...

    $10,000.00